JP2016539125A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016539125A5 JP2016539125A5 JP2016533206A JP2016533206A JP2016539125A5 JP 2016539125 A5 JP2016539125 A5 JP 2016539125A5 JP 2016533206 A JP2016533206 A JP 2016533206A JP 2016533206 A JP2016533206 A JP 2016533206A JP 2016539125 A5 JP2016539125 A5 JP 2016539125A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- weeks
- pharmaceutical composition
- progression
- structural damage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361907796P | 2013-11-22 | 2013-11-22 | |
| US61/907,796 | 2013-11-22 | ||
| US201462008787P | 2014-06-06 | 2014-06-06 | |
| US62/008,787 | 2014-06-06 | ||
| EP14306366.7 | 2014-09-05 | ||
| EP14306366 | 2014-09-05 | ||
| PCT/US2014/066856 WO2015077582A1 (en) | 2013-11-22 | 2014-11-21 | Compositions for the treatment of rheumatoid arthritis and methods of using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019209255A Division JP2020045351A (ja) | 2013-11-22 | 2019-11-20 | 関節リウマチを治療するための組成物およびこれを使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016539125A JP2016539125A (ja) | 2016-12-15 |
| JP2016539125A5 true JP2016539125A5 (enExample) | 2017-12-28 |
| JP6657089B2 JP6657089B2 (ja) | 2020-03-04 |
Family
ID=51518724
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533206A Active JP6657089B2 (ja) | 2013-11-22 | 2014-11-21 | 関節リウマチを治療するための組成物およびこれを使用する方法 |
| JP2021196599A Pending JP2022033891A (ja) | 2013-11-22 | 2021-12-03 | 関節リウマチを治療するための組成物およびこれを使用する方法 |
| JP2023202342A Pending JP2024026223A (ja) | 2013-11-22 | 2023-11-30 | 関節リウマチを治療するための組成物およびこれを使用する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021196599A Pending JP2022033891A (ja) | 2013-11-22 | 2021-12-03 | 関節リウマチを治療するための組成物およびこれを使用する方法 |
| JP2023202342A Pending JP2024026223A (ja) | 2013-11-22 | 2023-11-30 | 関節リウマチを治療するための組成物およびこれを使用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160280782A1 (enExample) |
| EP (2) | EP3770173A1 (enExample) |
| JP (3) | JP6657089B2 (enExample) |
| KR (3) | KR20160079121A (enExample) |
| CN (2) | CN106413748A (enExample) |
| AU (3) | AU2014352801B2 (enExample) |
| CA (1) | CA2930615C (enExample) |
| MX (2) | MX377190B (enExample) |
| PL (1) | PL3071230T3 (enExample) |
| SG (1) | SG10201804000TA (enExample) |
| WO (1) | WO2015077582A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| US9943594B2 (en) | 2011-10-11 | 2018-04-17 | Sanofi Biotechnology | Methods for the treatment of rheumatoid arthritis |
| MX377190B (es) * | 2013-11-22 | 2025-03-07 | Sanofi Biotechnology | Uso de un anticuerpo anti-il6r para el tratamiento de la artritis reumatoide. |
| JP7272794B2 (ja) | 2015-11-03 | 2023-05-12 | サノフィ・バイオテクノロジー | ブドウ膜炎および黄斑浮腫の処置のためのｉｌ６ｒ抗体を含む組成物およびそれを使用する方法 |
| EP3216461A1 (en) * | 2016-03-07 | 2017-09-13 | Sanofi Biotechnology | Compositions and methods for treating rheumatoid arthritis |
| SG10202012182YA (en) * | 2016-03-07 | 2021-01-28 | Sanofi Biotechnology | Compositions and methods for treating rheumatoid arthritis |
| KR102871642B1 (ko) | 2017-12-07 | 2025-10-15 | 자크로스 가부시키가이샤 | 포트가 부착된 백 및 캡이 부착된 백 |
| TWI868074B (zh) * | 2018-08-29 | 2025-01-01 | 美商再生元醫藥公司 | 用來治療患有類風濕性關節炎之個體的方法及組成物 |
| EP3917618A1 (en) | 2019-01-31 | 2021-12-08 | Sanofi Biotechnology | Anti-il-6 receptor antibody for treating juvenile idiopathic arthritis |
| JP2022545312A (ja) * | 2019-04-24 | 2022-10-27 | サノフィ・バイオテクノロジー | 関節リウマチの診断及び処置の方法 |
| MA56116A (fr) * | 2019-06-04 | 2022-04-13 | Stefano Fiore | Compositions et procédés de traitement de la douleur chez des sujets atteints de polyarthrite rhumatoïde |
| JP7373958B2 (ja) | 2019-09-27 | 2023-11-06 | 株式会社日立製作所 | 分析システム及び分析方法 |
| KR20210040735A (ko) | 2019-10-05 | 2021-04-14 | 양수현 | 천장 수납형 빨래 건조대 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US8080248B2 (en) * | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
| TWI589299B (zh) * | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| ES2799439T3 (es) * | 2013-11-22 | 2020-12-17 | Sanofi Biotechnology | Composiciones para el tratamiento de la artritis reumatoide y métodos de uso de las mismas |
| MX377190B (es) * | 2013-11-22 | 2025-03-07 | Sanofi Biotechnology | Uso de un anticuerpo anti-il6r para el tratamiento de la artritis reumatoide. |
-
2014
- 2014-11-21 MX MX2016006595A patent/MX377190B/es active IP Right Grant
- 2014-11-21 PL PL14812084T patent/PL3071230T3/pl unknown
- 2014-11-21 SG SG10201804000TA patent/SG10201804000TA/en unknown
- 2014-11-21 CN CN201480073774.5A patent/CN106413748A/zh active Pending
- 2014-11-21 EP EP20167644.2A patent/EP3770173A1/en active Pending
- 2014-11-21 CA CA2930615A patent/CA2930615C/en active Active
- 2014-11-21 WO PCT/US2014/066856 patent/WO2015077582A1/en not_active Ceased
- 2014-11-21 EP EP14812084.3A patent/EP3071230B1/en active Active
- 2014-11-21 US US15/034,531 patent/US20160280782A1/en active Pending
- 2014-11-21 KR KR1020167016059A patent/KR20160079121A/ko not_active Ceased
- 2014-11-21 AU AU2014352801A patent/AU2014352801B2/en active Active
- 2014-11-21 KR KR1020237036134A patent/KR20230155586A/ko not_active Ceased
- 2014-11-21 JP JP2016533206A patent/JP6657089B2/ja active Active
- 2014-11-21 KR KR1020227013977A patent/KR20220056254A/ko not_active Ceased
- 2014-11-21 CN CN202510671202.7A patent/CN120514847A/zh active Pending
-
2016
- 2016-05-20 MX MX2020011993A patent/MX2020011993A/es unknown
-
2020
- 2020-08-26 AU AU2020223706A patent/AU2020223706B2/en active Active
-
2021
- 2021-12-03 JP JP2021196599A patent/JP2022033891A/ja active Pending
-
2023
- 2023-11-30 JP JP2023202342A patent/JP2024026223A/ja active Pending
-
2024
- 2024-07-16 AU AU2024204881A patent/AU2024204881A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016539125A5 (enExample) | ||
| MX2015004565A (es) | Metodo y dispositivo para conmutacion de camaras. | |
| JP2014530226A5 (enExample) | ||
| IL278423B2 (en) | Fidi-1 / Fidi-AL1 inhibitors for cancer treatment | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| HRP20210250T1 (hr) | Učinkovita i djelotvorna kontrola serumskog fosfata za optimalno stvaranje kostiju | |
| WO2016065226A8 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| JP2016502515A5 (enExample) | ||
| WO2015165413A8 (zh) | 一种新型的稳定型抗体药物耦联物及其制备方法和用途 | |
| JP2016518337A5 (enExample) | ||
| IL292465B2 (en) | Neuroactive compounds and methods of use thereof | |
| WO2013059559A3 (en) | Compounds and methods for enhancing innate immune responses | |
| WO2012149186A3 (en) | Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use | |
| CN110114083A (zh) | 一种预防和治疗脂肪肝的方法 | |
| EP4434540A3 (en) | Humanized anti-il-1r3 antibodies | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| HK1218865A1 (zh) | 用於降低多发性硬化症中丘脑损伤的拉喹莫德 | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| JP2017512194A5 (enExample) | ||
| JP2017507142A5 (enExample) | ||
| WO2016086153A3 (en) | Use of hsp90 inhibitors for the treatment of hiv infections and aids | |
| CN109689652A (zh) | 稠杂环类衍生物、其制备方法及其在医学上的应用 | |
| HK1252514A1 (zh) | 包含与抗体组合施予的ido抑制剂的肿瘤治疗剂 | |
| WO2016105516A8 (en) | Methods of using smad7 antisense oligonucleotides | |
| JP2013523758A5 (enExample) |